Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.55 USD | -0.15% | +2.34% | 0.00% |
May. 14 | Metagenomi, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
May. 07 | HC Wainwright Starts Metagenomi With Buy Rating, $10 Price Target | MT |
Financials (USD)
Sales 2024 * | 39.33M | Sales 2025 * | 31.45M | Capitalization | 246M |
---|---|---|---|---|---|
Net income 2024 * | -112M | Net income 2025 * | -144M | EV / Sales 2024 * | 6.25 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 7.81 x |
P/E ratio 2024 * |
-1.95
x | P/E ratio 2025 * |
-2.02
x | Employees | 237 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 66.51% |
1 day | -0.15% | ||
1 week | +2.34% | ||
Current month | +2.66% | ||
1 month | +1.24% | ||
3 months | -43.73% |
Date | Price | Change | Volume |
---|---|---|---|
24-06-05 | 6.55 | -0.15% | 15 171 |
24-06-04 | 6.56 | -1.94% | 21,565 |
24-06-03 | 6.69 | +4.86% | 270,022 |
24-05-31 | 6.38 | -0.16% | 24,960 |
24-05-30 | 6.39 | -0.16% | 22,139 |
Delayed Quote Nasdaq, June 05, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
0.00% | 246M | |
+55.70% | 55.7B | |
+41.08% | 39.91B | |
-5.39% | 39.57B | |
-5.56% | 28.16B | |
+16.46% | 26.3B | |
-20.56% | 18.94B | |
+33.03% | 12.17B | |
+25.85% | 12.12B | |
+2.72% | 12.12B |
- Stock Market
- Equities
- MGX Stock